Liver failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Between 18 and 65 years old; 2. AST/ALT > 20 times ULN; 3. TBIL>10 x ULN; 4. PT-INR>1.5; 5.PLT>50*10E9/L; 6. Liver imaging showed no liver cancer; 7.Understand and voluntarily sign the informed consent form approved by the ethics committee;
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with HIV infection or other immunodeficiency diseases; 3.Patients with diabetes, autoimmune diseases, infarction caused by cardiovascular and cerebrovascular accidents, history of organ transplantation and other organs Dysfunction or failure; 4. Patients with active bleeding, diffuse intravascular coagulation, thrombosis or thrombotic disease; 5.Those who cannot comply with the study arrangement and sign the informed consent; 6. Can not return to the hospital regularly according to the study plan and follow up visitors; 7.Other conditions that the researchers judged were not suitable for inclusion;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coagulation function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function;Adverse reactions (e.g. local hypersensitivity, extubation, local bleeding, shock, death, etc.);Renal function; | — |
Countries
China
Contacts
Affiliated Hospital of Guangdong Medical University